Exercise Live Evidence Injury And Testing

---
name: exercise-live-evidence-injury-and-testing
description: "Use when interpreting current evidence or measuring an athlete: the live literature on resistance training dose-response and on exercise during GLP-1 therapy, injury and load management including workload monitoring and tissue tolerance, and testing — what the common field and laboratory tests actually measure and what they do not."
---

# Exercise Science: What's Live, Injury and Load Management, and Testing

> **Part 5 of 6** of the *Exercise Science and Physiology* reference (plugin `exercise-science-physiology`), covering §22–§24. Sibling skills: `exercise-physiology-muscle-energy-and-body-systems` (§0–§7), `exercise-training-principles-strength-endurance-and-recovery` (§8–§13), `exercise-programming-periodization-and-aging` (§14–§18), `exercise-fuelling-supplements-and-health-first` (§19–§21), `exercise-reference` (§25–§29). Section numbers are shared across the set; a reference written as §N → `skill` points into that sibling skill.
>
> **Currency:** The physiology is settled. Two areas are live. See §22 for the resistance training dose-response meta-analyses, and exercise during GLP-1 therapy.

> **⚠️ A field with a genuinely strong mechanistic core and an unusually noisy
> application layer.** **The physiology is well established; the training advice built on
> top of it is dense with confident folklore and commercial interest.**
>
> **⚠️ Scope and limits, stated plainly.** **This is a technical reference, not personal
> programming or medical advice.** ⚠️ **Population-level findings don't determine
> individual cases, individual response variance is large (§8 → `exercise-training-principles-strength-endurance-and-recovery`), and anyone with a medical
> condition, an injury, or who is pregnant, older, or returning from a long layoff should
> be working with a qualified professional rather than a document.**
> **⚠️ §21 → `exercise-fuelling-supplements-and-health-first` covers under-fuelling, overtraining and disordered patterns — that section
> matters more than the optimization sections, and I've put the reasoning there rather
> than as a disclaimer.**
>
> **⚠️ GOTCHA** boxes mark widely-repeated claims the evidence doesn't support.
>
> **The three ideas that organize this document:**
> 1. **⚠️ Adaptation is a response to a stress the body wasn't prepared for, followed by
>    recovery** (§8 → `exercise-training-principles-strength-endurance-and-recovery`). **No overload, no adaptation. No recovery, no adaptation either —
>    and the second half is where most people fail.**
> 2. **⚠️ Specificity dominates.** **You get better at what you do, in the range you do it,
>    at the speed you do it.** **Most "best exercise" arguments dissolve once you ask
>    "best for what?"**
> 3. **⚠️ Consistency over years beats optimization within a session by an enormous
>    margin** (§16 → `exercise-programming-periodization-and-aging`). **The programme you actually do is better than the optimal one you
>    don't.**

---

## §22. What's Live — verified August 2026

### 22.1 ⚠️ The resistance training dose-response, quantified
**⚠️ A February 2026 *Sports Medicine* meta-regression is the most rigorous attempt yet to
answer "how many sets?" — and its most useful contribution is methodological.**

- **⚠️ Scale: 67 studies, 2,058 participants, 220 hypertrophy effects and 490 strength
  effects, with models adjusted for intervention duration and training status.**
- **⚠️ The methodological advance — and this is the part practitioners should carry.**
  **The authors classified every set as DIRECT or INDIRECT relative to the muscle being
  measured**, ⚠️ **and found the best-fitting approach was "fractional" counting: indirect
  sets count as 0.5 rather than as 1 (total) or 0 (direct only).** **⚠️ So rows partially
  count toward biceps volume, and pressing partially counts toward triceps.** **The paper
  concludes that distinguishing direct from indirect sets "appears essential" for
  predicting adaptations** — **which means much older volume research, and most gym
  advice, was counting sets wrong.**
- **⚠️ Volume and hypertrophy: more is better, with diminishing returns.** **Posterior
  probability that the slope exceeds zero was 100%** — **gains increase as volume
  increases** — ⚠️ **but the best-fit models show diminishing returns.** **A prior analysis
  using direct measurements reported roughly 0.38% additional hypertrophy per added set,
  which conveys the scale: real, and small per set.**
- **⚠️ Volume and strength: also positive, with CONSIDERABLY MORE PRONOUNCED diminishing
  returns than for hypertrophy.**
- **⚠️ Frequency behaves differently for the two outcomes, and this is the cleanest
  practical finding.** ⚠️ **For hypertrophy, the probability of a frequency effect was
  below 100% — "compatible with negligible effects."** **For strength it was 100%:
  strength gains increase with frequency, with diminishing returns.**
  **⚠️ Read: if you're chasing SIZE, get your weekly volume in however it fits. If you're
  chasing STRENGTH, spread it across more sessions** — **consistent with §6 → `exercise-physiology-muscle-energy-and-body-systems`'s motor-learning
  point.**

> **⚠️ GOTCHA — read the sample before generalizing.** ⚠️ **Participants averaged ~25 years
> old and were 79.1% male.** **⚠️ Applying these curves to older adults, to women, or to
> highly advanced trainees is extrapolation.** **And "more volume is better with
> diminishing returns" is not licence for unlimited volume — ⚠️ the models describe
> adaptation, not the fatigue, time and injury costs of accumulating it** (§16 → `exercise-programming-periodization-and-aging`, §21 → `exercise-fuelling-supplements-and-health-first`).

**⚠️ A companion finding worth pairing with it**: **a meta-regression on proximity to
failure found that for STRENGTH, the relationship with reps-in-reserve was negligible** —
⚠️ **you don't need to approach failure to get stronger, provided load is sufficient** —
**while hypertrophy is more sensitive to it** (§9 → `exercise-training-principles-strength-endurance-and-recovery`).

### 22.2 ⚠️ Exercise during GLP-1 therapy
**⚠️ Genuinely reshaping applied exercise physiology, because a large population is now
losing weight rapidly under pharmacological appetite suppression.**

- **⚠️ The lean mass numbers are substantial.** **The STEP 1 body composition substudy
  reported roughly 45% of weight lost on semaglutide coming from lean tissue;
  SURMOUNT-1 reported about 25% for tirzepatide.** **Reported ranges across trials
  commonly run 25–40%.**
- **⚠️ The crucial interpretive point, and it cuts against the alarmism**: ⚠️ **that ratio
  is roughly NORMAL for rapid weight loss and is largely adaptive rather than a unique
  drug effect.** **⚠️ What differs is the ABSOLUTE amount — because the total weight loss
  is much larger.** **A patient losing 22% of 100 kg may lose 6–8 kg of fat-free mass
  without a prevention strategy.**
- **⚠️ And a measurement caveat that matters**: ⚠️ **DXA-derived lean mass and BIA-derived
  fat-free mass are not equivalent to skeletal muscle, and lean tissue loss does not
  necessarily indicate impaired strength or function.** **The field is being urged to move
  toward function — grip strength, physical performance — rather than lean mass alone.**

> **⚠️ GOTCHA — this is the clearest current case of exercise science being directly
> clinically load-bearing, and the intervention is exactly what §9 → `exercise-training-principles-strength-endurance-and-recovery` and §19 → `exercise-fuelling-supplements-and-health-first` already
> said.**
> ⚠️ **Resistance training plus adequate protein substantially reduces the lean mass
> loss.** **A systematic review reported resistance training 2–3× weekly during GLP-1
> therapy reducing fat-free mass loss by 30–50% versus no-exercise controls, without
> compromising fat loss.** ⚠️ **The S-LITE trial found supervised resistance and aerobic
> training plus adequate protein could preserve or even INCREASE lean mass alongside
> pharmacotherapy** — **an outcome not seen with the drug alone.**
> **⚠️ Protein targets cited in the clinical literature cluster around 1.2–1.6 g/kg/day,
> evenly distributed across meals, with reported diminishing returns above that** —
> ⚠️ **noting this is a CLINICAL weight-management range, below the §19 → `exercise-fuelling-supplements-and-health-first` athletic range,
> and that some case-series work used higher intakes relative to fat-free mass.**

**⚠️ Practical complications specific to this population**: ⚠️ **early satiety, nausea and
altered food preferences reduce dietary variety and total intake, creating micronutrient
risk (iron, B12, vitamin D, calcium, thiamine).** ⚠️ **Some patients reduce physical
activity during treatment due to fatigue — which removes the mechanical loading stimulus
exactly when it's most needed.** **⚠️ Older adults show greater proportional lean mass loss
and anabolic resistance** (§18 → `exercise-programming-periodization-and-aging`), **making them the priority group.**
⚠️ **Honest limits: a 2025 review calls the ideal protein dosing and the role of resistance
training during GLP-1 use "urgent research gaps," and pharmacological adjuncts
(myostatin inhibition — semaglutide with bimagrumab lowered the lean-mass fraction to ~7%
in phase 2) remain early with sparse functional endpoints.**

---

## §23. Injury and Load Management

**⚠️ The single most transferable idea: injury risk relates to RATE OF CHANGE in load more
than to absolute load.** ⚠️ **Rapid spikes in training load are associated with elevated
injury risk; well-built high loads are protective.** **⚠️ Note the acute:chronic workload
ratio specifically has been methodologically criticized** — **the underlying principle
holds better than that particular metric.**
**⚠️ What has the best injury-prevention evidence, and it isn't stretching** (§12 → `exercise-training-principles-strength-endurance-and-recovery`):
```
⚠️ STRENGTH TRAINING  the strongest single intervention across sports
⚠️ ECCENTRIC-BIASED work for specific tissues (Nordic curls for hamstrings,
   heavy slow resistance for tendinopathy) — well supported
NEUROMUSCULAR/BALANCE programmes  ⚠️ good evidence for ankle and ACL
⚠️ GRADUAL PROGRESSION and adequate sleep (§13)
```
**⚠️ Tendinopathy is degenerative rather than primarily inflammatory** — ⚠️ **"tendinitis"
is usually a misnomer** — **and it responds to progressive loading, not to rest.** **Rest
is the intuitive and usually wrong answer.**
**⚠️ Pain science**: **pain is an output of the nervous system, modulated by many factors,
and ⚠️ imaging findings correlate poorly with pain** — **disc bulges and rotator cuff
tears are common in asymptomatic people.** **⚠️ This matters practically: a scan finding is
not automatically the cause of the symptom.**

---

## §24. Testing

```
STRENGTH   1RM or estimated from submaximal; ⚠️ isometric dynamometry
POWER      vertical jump, ⚠️ velocity-based training metrics
AEROBIC    ⚠️ VO₂max (lab), field tests, critical power, FTP
THRESHOLD  ⚠️ lactate testing, ventilatory thresholds, talk test
BODY COMP  ⚠️ DXA, BIA, skinfolds — see the §22.2 caveat: these measure
           LEAN MASS, not muscle, and precision is worse than reported
READINESS  ⚠️ HRV, resting HR, subjective wellness questionnaires —
           ⚠️ subjective measures often outperform the devices
```
**⚠️ Reliability before validity**: ⚠️ **a test you administer inconsistently tells you
nothing about change**, **and most of the point of testing is tracking change over time
rather than a single absolute number.** **Standardize time of day, warm-up, equipment and
instructions, or don't bother comparing.**
**⚠️ Wearables**: **heart rate is reasonably accurate from chest straps and less so from
wrist optical sensors during high-intensity or resistance work; ⚠️ energy expenditure
estimates are poor; and "recovery scores" are proprietary composites with limited
independent validation.** ⚠️ **Useful for trends, not for decisions.**